children and adolescents, totaling 3.4 billion dollars (Bui et al., 2017) .
The high costs related to anxiety disorders draw focus on understanding and reducing healthcare utilization due to serious events.
ER visits, mental health-related hospitalizations, and self-harm place a significant burden on patients, caregivers, and the healthcare system (Deacon et al., 2008; Howell & Teich, 2008; Newton, Rosychuk, Niu, Radomski, & McGrath, 2016; Sinclair, Gray, Rivero-Arias, Saunders, & Hawton, 2011; Zima et al., 2016) . Suicide is the third leading cause of death in children aged 5-14 years and second in adolescents 15-24 years (CDC/NCHS, 2018) . Mental health-related hospitalizations are relatively common in children with mental health diagnoses and costly (Howell & Teich, 2008; Torio, Encinosa, Berdahl, McCormick, & Simpson, 2015) . Anxiety ranked sixth (of 531) in most common chronic conditions in pediatric acute-care hospitalizations (Berry et al., 2017) , and accounted for a growing proportion of pediatric hospitalizations from 2005 to 2014 (Zima et al., 2016) . Annually, almost one in five U.S. children has an ER visit, with injury being a common cause (National Center for Health Statistics, 2013) , and over 1 million ER visits occurred with anxiety the primary reason for the visit, 7% of which occurred in children (Dark et al., 2017) .
Previous work provided important insights into how many children with mental health diagnoses experience ER visits and hospitalizations in a year (Howell & Teich, 2008) and how often anxiety is the reason for pediatric ER visits and hospitalizations (Dark et al., 2017; Newton et al., 2016; Torio et al., 2015; Zima et al., 2016) . However, it is less clear how many children diagnosed with anxiety go on to experience each event, rather than how many events are attributable to anxiety.
Using longitudinal data to determine the incidence of ER visits, mental health hospitalizations, and treated self-harm in children newly diagnosed with an anxiety disorder extends the existing literature.
Cumulative incidence estimates of these serious, impactful events can increase clinician, caregiver, and patient awareness at diagnosis, a time when information may be particularly sought-after. This information can contribute to the clinician's larger discussion with caregivers and patients on the importance of managing symptoms, when to seek additional care, and the impact of comorbid psychiatric conditions. Further, estimates can help policymakers predict healthcare utilization and inform prevention efforts.
In a cohort of commercially insured children newly diagnosed with an anxiety disorder in an office setting, we aimed to estimate the 2-year cumulative incidence of mental health-related hospitalizations, inpatient, treated self-harm, and ER visits. Additionally, we estimated the 2-year cumulative incidence of these events in a similar population of commercially insured children without a diagnosed anxiety disorder to provide context and better understand baseline event incidence in absence of anxiety disorder diagnoses.
METHODS

Data source & study population
We used Truven Health Analytics' MarketScan Commercial Claims and Encounters database (Hansen & Chang, 2011) , which contains health plan data for individuals covered by employer-sponsored private health insurance across the United States. We utilized data on inpatient admissions and services, outpatient services, outpatient dispensed prescriptions, and enrollment files from January 1, 2004 to December 31, 2014. We identified children (3-17 years) newly diagnosed with an anxiety disorder from 2005 to 2014. An anxiety diagnosis was defined as an 300.0×, 300.2×, 300.3×, 309.21, 309.81, and 313.23) corresponding to anxiety disorders in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) (American Psychiatric Association, 2013), along with posttraumatic stress disorder (PTSD), or obsessive-compulsive disorder (OCD), which were previously grouped under anxiety disorders in the DSM-IV. We required children to have at least 1 year of insurance enrollment (with prescription and mental health services coverage) prior to the first recorded anxiety disorder diagnosis (Supporting Information Figure S1 ) to increase the likelihood that we identified a new diagnosis. We excluded children with a prior year diagnosis of bipolar disorder (296.0× and 296.4×-.8×), personality disorder (301.×), schizophrenia (295.×), and autistic disorder (299.00) given more complex history and treatment regimens.
We restricted the cohort to children naïve to anxiety treatment during the year before their anxiety disorder diagnosis, including psychotherapy (based on recorded CPT codes) or dispensed SSRI prescriptions, benzodiazepines (alprazolam, chlordiazepoxide, clobazam, clonazepam, clorazepate, diazepam, halazepam, lorazepam, oxazepam, and prazepam) , buspirone, other antidepressants, hydroxyzine, or antipsychotics. We allowed baseline prescriptions for medications that are sometimes used to treat anxiety (e.g., beta-blockers, anticonvulsants, and clonidine/guanfacine) because these medications are rarely the initial anti-anxiety pharmacotherapy (Bushnell et al., 2018) and have primary nonanxiety indications. Finally, we restricted the cohort to children with their new anxiety diagnosis in an office setting (83%) to create a more similar, clinically relevant cohort. In preliminary analyses, cumulative incidences were higher during follow-up when allowing new anxiety diagnoses from all settings; however, children diagnosed with anxiety outside an office (i.e., inpatient, ER, and urgent care) likely had a different trajectory leading to their diagnosis.
Incident event definitions
Events were identified beginning the day after the new anxiety disorder diagnosis for up to 2 years. A mental health-related hospitalization was defined as an inpatient admission with a recorded psychiatric diagnosis (ICD-9-CM = 290-319); a secondary definition required a psychiatric diagnosis in the primary diagnostic position. An inpatient, treated self-harm event was defined as an inpatient record for suicide and self-inflicted injury (ICD-9-CM = E950-E958; Centers for Disease Control and Prevention, 2011) . We also examined recorded suicidal ideation (ICD-9-CM = V62.84). ER visits included claims with ER designated as the category of service (Truven Health Analytics Inc., 2011). Anxiety-related ER visits required a diagnostic code for anxiety (cohort inclusion anxiety disorder codes, adjustment disorder with anxiety [ICD-9-CM = 309.24 and 309.28], or acute stress disorder [ICD-9-CM = 308.×]). Injury-related ER visits required an ICD-9-CM diagnostic code 800-999 or E800-999 (excluding late effects = 905-909, E929, E959, E969, E977, E989, and E999 and place of injury = E849).
Comparison cohort
A comparison cohort was created to estimate event incidence in children with the same restrictions as the anxiety cohort (except for an anxiety diagnosis) and identical event definitions. To create the comparison cohort, we selected all children in the dataset that matched with a child in the anxiety cohort on age, sex, date, and geographical region (North Central, Northeast, South, and West; Supporting Information Figure S1 ). For the match on date, we required eligible matches to have a diagnostic code recorded on the exact date a child was diagnosed with anxiety, termed "match date." From the 15 million children who matched with at least one child on those four criteria, we applied the same baseline inclusion criteria used for the anxiety cohort, resulting in 8 million children who matched with at least one child in the anxiety cohort (Supporting Information Figure S1 ). From that pool of eligible matches, we randomly selected 10 per child in the anxiety cohort; a child in the comparison cohort could match once. All children in the database were eligible as potentially matches. As we ignored future claims when selecting the cohort (Lund et al., 2017) , a small subset (3%) of children in the comparison cohort was also in the anxiety cohort. Covariate and event definitions were consistent with the anxiety cohort.
Primary patient covariates
For each child, age, sex, year of first anxiety diagnosis (or match date), provider type of anxiety diagnosis (or match date diagnoses), and, for the anxiety cohort, specific anxiety disorder diagnosis were included.
In the year prior to a child's new anxiety diagnosis (or match date), we created indicators for psychiatric and nonpsychiatric comorbidities, inpatient and outpatient visits, ER visits, and medication use.
A primary stratification variable was psychiatric conditions in the prior year, defined as (1) no psychiatric comorbidity diagnosis, (2) comorbid depression diagnosis (ICD-9-CM = 296.2×, 296.3×, 300.4×, 309.1×, or 311.××), and (3) other psychiatric comorbidity (ICD-9-CM = 290-319, excluding anxiety disorder and depression diagnoses and excluded baseline comorbidities = bipolar disorder, personality disorder, schizophrenia, and autistic disorder). As the study cohort was restricted to treatment naïve children, a proportion of children previously treated for psychiatric comorbidities were, by default, excluded.
Statistical analysis
We described the anxiety and comparison cohorts. We used KaplanMeier estimator to estimate 2-year cumulative incidence and associated 95% confidence intervals (CI) of each incident event (log-log transformation). When calculating cumulative incidence of each event, children were followed until that event occurred or were censored at insurance disenrollment, end of data (12/31/2014), or 2 years after their anxiety diagnosis (or match date), whichever occurred first. We stratified results by most common initial anxiety disorder diagnoses, age group, and psychiatric comorbidity; in the comparison cohort, we present event incidence in children without any recorded baseline psychiatric diagnosis. The analysis for recorded suicidal ideation was restricted to children diagnosed with anxiety (or match date) in 2006 or later, based on ICD-9-CM code availability. For a sensitivity analysis, we stratified results by the presence of a follow-up anxiety disorder diagnosis within 90 days of the first diagnosis; a single diagnostic code may not represent a true diagnosis. In an additional sensitivity analysis, cumulative incidence was estimated after excluding children with prior psychiatric-related inpatient admission or recorded suicidal ideation or self-harm, events are strong predictors of some events under consideration. Analyses were completed with SAS version 9.4, Cary, NC.
The University of North Carolina Institutional Review Board approved this study.
RESULTS
The cohort included 198,450 children with a new office-based anxiety disorder diagnosis; the median age was 12 years (interquartile range = 8-15 years) and 45% were male ( Table 1) . The majority had a new anxiety diagnosis for unspecified anxiety disorder (53%), followed by generalized anxiety disorder (25%), OCD (5%), and PTSD (4%). A psychiatrist or psychologist/therapist diagnosed 46% of children with anxiety followed by 21% diagnosed by a pediatrician. Six percent of children had a baseline depression diagnosis, of whom 86% had depression diagnosed at least 30 days prior to the anxiety diagnosis.
Ten matches were identified for >99% of children in the anxiety cohort to create the comparison cohort (N = 1,980,082). The comparison cohort had a lower baseline prevalence of recorded psychiatric comorbidities, medication utilization, outpatient visits, and certain nonpsychiatric comorbidities (Table 1) . Among the most common (top 70%) ICD-9-CM diagnoses recorded on the match date in the comparison cohort, 37% were related to a vaccination or routine visit, 32% general acute concern (e.g., fever and ear infection), 8% injury/painrelated, 3% psychiatric diagnoses, 11% conditions likely requiring repeat visits (e.g., acne and chronic rhinitis), and 9% potentially more severe, chronic conditions (e.g., asthma, obesity, and unspecified chest pain). Eighty percent of children with anxiety and 85% of the comparison cohort had at least 6 months of follow-up (1 year = 61% and 73%, respectively). Table 2 displays cumulative incidence of each event at 1, 6, 12, and 24 months following a new anxiety disorder diagnosis. Within 1 year, 2.0% of children had a mental health-related hospitalization; 1.7% (95% CI = 1.6-1.8) when restricting to hospitalizations with a primary mental health diagnosis. Around 0.08% children had an inpatient, treated self-harm event 1 year after a new anxiety disorder diagnosis and 1.0% had a recorded suicidal ideation claim. ER visits were common; 20% of children had an ER visit, 9% an injury-related ER visit, and 1.4% an anxiety-related ER visit within 1 year after a new anxiety disorder diagnosis. The 2-year incidence of each event was similar 2007-2009 (19%), 2010-2012 (39%), 2013-2014 (34%) . b Anxiety cohort: agoraphobia 0.4%; anxiety due to medical condition 0.5%; social phobia 1.8%; other, specific phobia 1.5%; other anxiety 1.1%; selective mutism 0.5%; multiple specific anxiety diagnoses 0.7%. c ICD-9-CM code for abdominal pain, unspecified chest pain, headache, hyperventilation, malaise/fatigue, nausea, palpations, or weight loss. d Children with a baseline diagnosis of bipolar disorder, personality disorder, schizophrenia, or autistic disorder were excluded from both cohorts. e Inpatient admission: psychiatric = inpatient admission associated with ICD-9-CM diagnosis 290-319.
Cumulative incidence, anxiety cohort
TA B L E 1 Patient characteristics of children newly diagnosed with anxiety and children in the comparison cohort
in children with an unspecified anxiety or generalized anxiety disorder (GAD) diagnosis and higher in children with a PTSD diagnosis (Supporting Information Table S2 ).
Cumulative incidence, comparison cohort
The 2-year cumulative incidence of each event was lower in the comparison cohort compared to the anxiety cohort (Table 2 ). One year after the match date, 0.5% of children had a mental health-related hospitalization (0.4% with a primary mental health diagnosis), 0.01% an inpatient, treated self-harm event, 13% an ER visit, and 7% an injuryrelated ER visit.
Age and psychiatric comorbidity stratification
In children with newly diagnosed anxiety, the 2-year cumulative incidence of each event varied by age at diagnosis and baseline psychiatric comorbidities (Figure 1 ; Table 3 ). The cumulative incidence of mental health-related hospitalizations (6 months = 5.1%, 95% CI = 4.6-5.6), inpatient, treated self-harm (6 months = 0.43%, 95% CI = 0.30-0.60), and anxiety-related ER visits (6 months = 2.2%, 95% CI = 1.9-2.6) following a new anxiety diagnosis occurred more frequently in children 14-17 years with comorbid depression compared to other age and comorbidity groups (Figure 1 ). Of note, CIs are slightly wider in stratified analyses given smaller sample per strata (Table 3) .
Restricting the comparison cohort to children without baseline psychiatric diagnoses (N = 1,805,682, 91%), the 1-year cumulative incidence estimates remained lower than in children with anxiety disorders and no psychiatric comorbidity (Table 3 ). For example, 2.7% of children 14-17 years in the anxiety cohort with no psychiatric comorbidity had a mental health-related hospitalization and 0.12% an inpatient, treated self-harm event within 1 year, compared to 0.6% and 0.02%, respectively, in the comparison cohort with no psychiatric diagnosis.
Sensitivity analyses
In children with a follow-up anxiety disorder diagnosis within 90 days (n = 113,437; 57%), 1-year incidence of ER visits overall and injuryrelated ER visits were similar to children without a follow-up diagnosis (n = 85,013). The cumulative incidence of inpatient, treated selfharm, mental health-related hospitalizations, and anxiety-related ER visits were higher in children with a follow-up anxiety diagnosis (Supporting Information, Table S1 ). After excluding 0.5% (n = 968) of the anxiety cohort and 0.1% (n = 2,073) of the comparison cohort with baseline psychiatric hospitalizations or recorded suicidality, results, not shown, were consistent (e.g., 1-year incidence of mental health TA B L E 2 Cumulative incidence of serious events in children following a new anxiety diagnosis (N = 198,450) 
DISCUSSION
In this cohort of privately insured children, many experienced a serious healthcare-related event in the 2 years following their new anxiety diagnosis; incidence of each event was lower in children without anxiety disorders. With 54 million children worldwide estimated to have an anxiety disorder (Global Burden of Disease Pediatrics Collaboration, 2016), incidence estimates translate to a significant number of children with anxiety experiencing each event and a sizable burden on the healthcare system. Our findings offer caregivers, providers, and patients a better understanding on the impact of anxiety disorders, which can inform care decisions. Further, findings underscore research efforts to prevent these serious events.
The event incidence in children with diagnosed anxiety and context provided by the comparison cohort suggest many children with anxiety disorders need improved care. Despite impairments, many children with mental health problems do not receive professional care (Rickwood, Deane, & Wilson, 2007) . A third or less of adolescents with anxiety disorders reported receiving care; lower than adolescents with depression and attention-deficit/hyperactivity disorder (Chavira, Stein, Bailey, & Stein, 2004; Merikangas et al., 2011; . For children with mild anxiety, education and support may help manage symptoms, but anxiety should be monitored at follow-up visits (Ramsawh et al., 2010) . We observed higher incidence of psychiatricrelated events in children with follow-up anxiety diagnoses, possibly a consequence of children with more severe anxiety receiving followup diagnoses. As pediatric anxiety disorders can be chronic and persistent (Wehry, Beesdo-Baum, Hennelly, Connolly, & Strawn, 2015) and management of anxiety disorders can positively impact health outcomes and economic production (Chisholm et al., 2016) , future research should examine when and how to optimize care to reduce event occurrence.
Consistent with prior findings, we observed higher incidence in older children. The rate of ER visits for anxiety or stress disorders increases substantially across childhood (Newton et al., 2016) , as does the national suicide rate (Perou et al., 2013) . We observed higher incidence in children with diagnosed depression; higher medical costs F I G U R E 1 Cumulative incidence following a new anxiety diagnosis of: (a) mental health related hospitalizations (not displayed = children with another diagnosed psychiatric comorbidity, included N = 156,781); (b) treated inpatient self-harm (restricted to children aged 14-17 years at new anxiety diagnosis, included N = 76,936); and (c) anxiety-related ER visits (not displayed = children with another diagnosed psychiatric comorbidity and, due to low event count, children 3-9 with comorbid depression, included N = 155,725) by age at anxiety diagnosis and psychiatric comorbidity diagnosed at baseline; *no psychiatric comorbidity diagnosed at baseline, **other psychiatric comorbidity: this excludes children with a baseline diagnosis of depression, bipolar disorder, personality disorder, schizophrenia, and autistic disorder prevalent in individuals with anxiety disorders (Kessler, Chiu, Demler, & Walters, 2005) , is strongly associated with suicidal behavior (Cash & Bridge, 2009 ); therefore, monitoring suicide risk in children with anxiety and comorbid depression is recommended (Connolly et al., 2007) . Given our baseline restrictions (e.g., treatment naïve), examination of children with new anxiety disorder diagnoses, and later onset of depression than pediatric anxiety disorders , only 6% of our cohort had diagnosed depression. Understanding if, and when, depression symptoms developed following an anxiety diagnosis would further inform results.
Our self-harm definition required a claim with an external cause of injury code, which often have low sensitivity but high specificity in identifying suicide attempts (Kim et al., 2012; Lu et al., 2014; Walkup, Townsend, Crystal, & Olfson, 2012) . Relatedly, suicidal ideation and the corresponding diagnostic code are typically missing from patient records Kemball, Gasgarth, Johnson, Patil, & Houry, 2008) . Therefore, our observed inpatient, treated self-harm and suicidal ideation incidences represent a fraction of all events and can be viewed as a lower limit of the true 2-year incidence.
Prior studies found adults with anxiety disorders to have higher mental health-related inpatient admissions, inpatient visits, and ER visits than controls, including adults with anxiety and no depression (Marciniak, Lage, Landbloom, Dunayevich, & Bowman, 2004; McLaughlin et al., 2006) , and adults with PTSD had an increased incidence of suicide than controls (Gradus et al., 2015) . We additionally observed a higher incidence of injury-related ER visits in children with anxiety disorders than the comparison cohort, our event least directly related to anxiety disorders. Over-anxious disorder symptoms predicted unintentional injuries in children (Rowe, Simonoff, & Silberg, 2007) ; potential explanations included parents of anxious children may be more likely to report injuries (in our case, this could be related to going to the ER) and children with anxiety may react more strongly to less severe injuries (Rowe et al., 2007) . However, further research is needed to explore potential causality. In children without a baseline psychiatric diagnosis, 2-year cumulative incidence of each event remained higher in children with anxiety than the comparison cohort, which may be particularly useful for clinicians and parents to understand and anticipate risks in children with anxiety alone. , 2006) . The higher healthcare utilization and comorbidity diagnoses we observed could be related to anxiety symptoms before diagnosis, such as somatic symptoms, which are common in pediatric anxiety (Crawley et al., 2014; Ginsburg, Riddle, & Davies, 2006; Ramsawh et al., 2010) . Observed differences in 2-year cumulative incidence between anxiety and comparison cohorts may be due to baseline differences, which are part of the full picture when estimating event occurrence in individuals with and without anxiety disorders.
Our study population represents a subset of all U.S. children with anxiety disorders. Research in U.S. children covered by Medicaid and uninsured children would complement our findings. Further, the median age in our sample was 12 years, whereas the median age of onset for adolescences with anxiety disorders was 6 years . The major distinction is that our cohort restricts to children with recorded anxiety disorder diagnoses from a healthcare provider. Delays in seeking care are common; among adults, the median delay in initial treatment contact for anxiety disorders was 9 to 23 years (Wang et al., 2005) . Relatedly, the higher incidence we observe in older children could partially be attributed to children with longer periods of untreated, unrecognized anxiety.
The research can be applied to help providers inform and prepare caregivers and patients on risks, monitoring symptoms, and when to seek additional care to prevent serious events. As parents commonly report unmet needs for care coordination in pediatric anxiety (Brown, Green, Desai, Weitzman, & Rosenthal, 2014) , efforts are needed to help practitioners facilitate patient mental health care. Implications of the research on the healthcare system include anticipation of healthcare needs in children with anxiety and encouragement of facilities to be aware of anxiety disorders in pediatric admissions.
Given children with anxiety often receive care outside mental health specialists (Anderson, Chen, Perrin, & Van Cleave, 2015) , educating emergency medicine practitioners and practitioners of pediatrics and family practice in optimal management of pediatric mental illness is essential (Dolan, Fein, & Committee on Pediatric Emergency Medicine, 2011) . For example, integration of mental health specialist in ERs and primary care could help reduce repeated anxiety-related ER visits (Dark et al., 2017 Within 2-years following a new anxiety disorder diagnosis, a significant proportion of children have a mental health-related hospitalization, inpatient treated self-harm event, or ER visit, which translates to a sizable number of children given the prevalence of anxiety disorders.
Describing the 2-year cumulative incidence of each event adds to understanding the impact and burden of pediatric anxiety disorders.
This information can encourage proper management of anxiety disorders, help anticipate healthcare utilization, and focus research efforts within pediatric anxiety to prevent these serious events.
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